Abstract
A neutral protease with an estimated Mr of about 26 kD and responsible for cleavage of myosin LC2 was isolated from hamster skeletal muscle. Complementary DNAs were generated by RT-PCR using total hamster muscle RNA and degenerate oligonucleotide primers based on the sequences of two internal peptides. The nucleotide sequences of the resultant cDNAs were subsequently determined and the complete amino acid sequence of the protease deduced. Although the hamster protein shared 63-85% identity in nucleotide and amino acid sequences with rat and mouse mast cell proteases, it had a higher degree of specificity for myosin LC2 than mast cell proteases which also digested myosin LC1 and myosin heavy chains. As a result, the hamster protease was designated mekratin because of its unique enzymatic specificities to distinguish it from other mast cell proteases. A polyclonal antibody was raised specific to the hamster muscle and human cardiac muscle mekratins without apparent cross-reaction with rat mast cell proteases. We have earlier demonstrated the presence in excess of a neutral protease that specifically cleaves LC2 in human hearts obtained at end stage idiopathic dilated cardiomyopathy (IDC). Western analyses revealed that heart tissue from patients with IDC contained 5-10 fold more mekratin than control samples. Furthermore, the level of the protease in human IDC tissues was similar to that seen in myopathic hamster skeletal muscle. No bands were recognized by the antibody when IDC myofibrils were probed due to the removal of soluble proteins during sample preparation. Thus, these results strongly suggest that the anti-mekratin antibody will provide positive identification of IDC in many cases and diagnosis by exclusion may be replaced.
Similar content being viewed by others
References
Bhan AK, Malhotra A, Hatcher VB: Partial characterization of a protease from cardiac myofibrils of dystrophic hamsters. In: D Doyle, E Sega (eds). Protein Turnover and Lysosome Function. Academic Press, New York, 1978, pp 607–618
Bhan AK, Malhotra A, Hatcher VB, Sonnenblick EH, Scheuer J: Depressed myosin ATPase activity in hearts of myopathic hamsters: Dissociation from neutral protease activity. J Mol Cell Cardiol 10: 769–777, 1978
Malhotra A, Huang S, Bhan AK: Subunit function in cardiac myosin: Effect of removal of LC2 (18,000 molecular weight) on enzymatic properties. Biochemistry 18: 461–467, 1979
Margossian SS, Bhan AK, Slayter HS: Role of the regulatory light chains in skeletal muscle actomyosin ATPase and in minifilament formation. J Biol Chem 258: 13359–13369, 1983
Margossian SS: Reversible dissociation of dog cardiac myosin regulatory light chain 2 and its influence on ATP hydrolysis. J Biol Chem 260: 13747–13754, 1985
Kuo TH, Giacomelli F, Kithier K, Malhotra A: Biochemical characterization and cellular localization of serine protease in myopathic hamster. J Mol Cell Cardiol 13: 1035–1049, 1981
Kuo T, Bhan A: Studies of a myosin-cleaving protease from dystrophic hamster heart. Biochem Biophys Res Commun 92: 570–576, 1980
Margossian SS, Chantler PD, Sellers JS, Malhotra A, Stafford WF, Slayter HS: Proteolytic susceptibility of both isolated and bound light chains from various myosins to myopathic hamster protease. J Biol Chem 259: 13534–13540, 1984
Patella V, Marino I, Lamparter B, Arbustini E, Adt M, Marone G: Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol 154: 2855–2865, 1995
Ito BR, Engler RL, del Balzo U: Role of cardiac mast cells in complement C5a-induced myocardial ischemia. Am J Physiol 264: H1346–H1354, 1993
Patella V, Genovese A, Marone G: What are human heart mast cells for? Chemical Immunology 62: 171–186, 1995
Marone G, Patella V, de Crescenzo G, Genovese A, Adt M: Human heart mast cells in anaphylaxis and cardiovascular disease. Int Arch Allergy Immunol 107: 72–75, 1995
Remington SJ, Woodbury RG, Reynolds RA, Matthews BW, Neurath H: The structure of rat mast cell protease II at 1.9 A resolution. Biochemistry 27: 8097–8105, 1988
Lobe CG, Finlay BB, Paranchych W, Paetkau VH, Bleackley C: Novel serine proteases encoded by two cytosolic T lymphocyte-specific genes. Science 232: 858–861, 1986
Benfey PN, Yin FH, Leder P: Cloning of the mast cell protease, RMCP II. J Biol Chem 262: 5377–5384, 1987
LeTrong HL, Neurath H and Woodbury RG. Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells. Proc Natl Acad Sci USA 84: 364–367, 1987
Serafin WE, Reyholds DS, Rogelj S, Lane WS, Conder GA, Johnson SS, Austen KF, Stevens RL: Identification and molecular cloning of a novel mouse mucosal mast cell serine protease. J Biol Chem 265: 423–429, 1990
Serafin WE, Sullivan TP, Conder GA, Ebrahimi A, Marcham P, Johnson SS, Austen KF, Reynolds DS: Cloning of the cDNA and gene for mouse mast cell protease 4: Demonstration of its late transcription in mast cell subclasses and analysis of its homology to subclass-specific neutral proteases of the mouse and rat. J Biol Chem 266: 1934–1941, 1991
Newlands GF, Knox DP, Pirie-Shepherd SR, Miller HR: Biochemical and immunological characterization of multiple glycoforms of mouse mast cell protease 1: Comparison with an isolated murine serosal mast cell protease (MMCP-4). Biochem J 294: 127–135, 1993
Urata H, Kinoshita A, Misono MS, Bumpus FM, Husain A: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265: 22348–22357, 1990
Bhan AK, Malhotra A, Scheuer J, Conti MA, Adelstein RS: Subunit function in cardiac myosin: Effects of binding phosphorylated and unphosphorylated myosin light chain 2 to light chain 2-deficient myosin. J Biol Chem 256: 7741–7743, 1981
Margossian SS, Caulfield JB, Slayter HS: Activation of a protease during idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 26: S50/CXLVI, 1994
Margossian SS, White HD, Caulfield JB, Norton P, Taylor S, Slayter HS: Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy: Identification of a causal agent for impaired myocardial function. Circulation 85: 1720–1733, 1992
Laemmli UK: Cleavage of structural proteins in the assembly of bacteriophage T4. Nature (London) 277: 680–685, 1970
Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102: 196–202, 1980
Brown PD, Levy AT, Margulies IMK, Liotta LA, Stetler-Stevenson WG: Independent expression and cellular processing of Mr 72,000 Type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184–6191, 1990
Holt JC, Caulfield JB, Norton P, Chantler PD, Slayter HS, Margossian SS: Human cardiac myosin light chains: Sequence comparisons between myosin LC1 and LC2 from normal and idiopathic dilated cardiomyopathic hearts. Mol Cell Biochem 145: 89–90, 1995
Liu F-T, Zinnecker M, Hamaska T, Katz DH: New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry 18: 690–697, 1979
Polson A, von Wechmar MB, van Regenmortel MHV: Isolation of viral IgY antibodies from yolks of immunized hens. Immunol Comm 9: 475–493, 1980
Gassmann M, Thommes P, Weiser T, Hubscher U: Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J 4: 2528–2532, 1990
Margossian SS, Krueger JW, Sellers JR, Cuda G, Caulfield JB, Norton P, Slayter HS: Influence of the cardiac myosin hinge region on contractile activity. Proc Natl Acad Sci USA 88: 4941–4945, 1991
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76–85, 1985
Bhan AK, Kuo T: Studies of a myosin-cleaving protease from dystrophic hamster heart. Biochem Biophys Res Commun 92: 570–576, 1980
Shiota N, Fukamizu A, Takai S, Okunishi H, Murakami K: Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart. J Hypertens 15: 431–440, 1997
von Heinji G: How signal sequences maintain cleavage specificity. J Mol Biol 173: 243–251, 1984
Carne T, Scheele G: In: M Cantin (ed). Cell Biology of the Secretory Process. S. Karger, Basel, 1985 pp 73–101
Caughey GH, Raymond WW, Vanderslice P: Dog mast cell chymase: molecular cloning and characterization. Biochemistry 29: 5166–5171, 1990
Urata H, Kinoshita A, Perez DM, Misono KS, Bumpus FM, Graham RM, Husain H: Cloning of the gene and cDNA for human heart chymase. J Biol Chem 266: 17173–17179, 1991
Urata H, Karnik SS, Graham RM, Husain A: Dipeptide processing activates recombinant human prochymase. J Biol Chem 268: 24318–24322, 1993
Margossian SS, Anderson PAW, Norton P, Caulfield JB, Chantler PD, Slayter HS: Altered control of troponin T gene and increased activity of mekratin, a protease, in dilated cardiomyopathy. J Mol Cell Cardiol 27: A108, 1995
Silver M, Silver MS: In: MS Silver and M Silver (eds). Cardiomyopathies. 2nd edn. Cardiovascular Pathology Vol. 1. Churchill Livingston, New York, 1991 pp 743–810
Sinagra G, Raker S: Nonpredictive value of fibrosis in dilated cardiomyopathy treated with metoprolol. Cardiovasc Pathol 5: 21–28, 1996
Burch GE, Walsh JJ, Ferrans VJ, Hibbs R: Prolonged bed rest in the treatment of the dilated heart. Circulation 32: 852–856, 1965
Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, Macris MP, Delgado R, Buja LM: Improved left ventricular function after chronic left ventricular unloading. Ann Thora Surg 62: 675–682, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holt, J.C., Hatchert, V.B., Caulfield, J.B. et al. Cloning of the cDNA and nucleotide sequence of a skeletal muscle protease from myopathic hamsters. Mol Cell Biochem 181, 125–135 (1998). https://doi.org/10.1023/A:1006842332340
Issue Date:
DOI: https://doi.org/10.1023/A:1006842332340